Study sets, textbooks, questions
Upgrade to remove ads
Non-Proctored Pharmacology ATI Remediation
Terms in this set (27)
Antibiotics Affecting the Bacterial Cell Wall: Interventions for Urticaria
1. If a patient develops urticaria after taking cephalexin or another cephalosporin the medication should be stop immediately.
2. The provider should be notified when the patient develops urticaria after taking an antibiotic.
3. Hives can develop as an allergic reaction to penicillins, the patient should report this because the medication will likely be stopped.
Chp 44 pg 594
Antibiotics Affecting the Bacterial Cell Wall: Caring for a Client Who Has a Penicillin Allergy
1. The nurse should encourage the client with an allergy to penicillin to wear an allergy identification bracelet.
2. Those who have an allergy to one penicillin should be considered to have a cross-allergy to all types of penicillins and at a high risk for a cross-allergy to cephalosporin.
3. The nurse should always interview the patient regarding allergies before giving penicillin.
Chp 44 pg 593
Angina: Medication Error Requiring an Incident Report
1. It would be incorrect to give a patient nitroglycerin if they had a traumatic head injury because it could increase intracranial pressure.
2. It would be an error to give a patient with a prolonged QT ranolazine.
3. It is an error to give a patient who is taking nitroglycerin a PDE5 inhibitor such as sildenafil or tadalafil because it could cause life-threatening hypotension.
Chp 22 pg 285
Anxiety and Trauma‑ and Stressor‑Related Disorders: Interventions for Diazepam Toxicity
1. If it is oral diazepam toxicity, gastric lavage should be used followed by either activated charcoal or saline cathartics.
2. If it is IV diazepam toxicity, the nurse should administer flumazenil.
3. The nurse should provide fluids to maintain blood pressure as well as maintain a patent airway and monitor vital signs.
Chp 7 pg 4
Antilipemic Agents: Monitoring for Adverse Effects of Atorvastatin
1. A patient on atorvastatin should monitor their liver function tests after 12 weeks and every 6 months after that.
2. An adverse effect of atorvastatin is hepatotoxicity which can be monitored by increase AST levels.
3. A patient on atorvastatin needs to monitor CK levels to assess the adverse effect of myopathy.
Chp 24 pg 309
Growth Factors: Monitoring for Adverse Effects of Epoetin Alfa
1. A patient taking epoetin alfa should monitor their blood pressure and hematocrit for hypertension because of elevations of hematocrit.
2. Hemoglobin levels should be monitored in patients taking epoetin alfa for levels higher than 11 g/dL or increases more than 1 g in 2 weeks for the adverse effect of increased risk of thrombotic event.
3. If the patient is preoperative they can experience the adverse effect of epoetin alfa, increased risk for deep-vein thrombosis.
Chp 26 pg 342
Gastrointestinal Disorders: Monitoring for Adverse Effects of a Metoclopramide
1. Sedation is an adverse effect of metocolpramide, so the patient should avoid activities that require alertness.
2. A patient on metoclopramide should monitor their bowel function for the adverse effect of diarrhea.
3. An adverse effect of metoclopramide is extrapyramidal symptoms, the patient should be monitored for restlessness, anxiety, and spasms of the neck and face.
Chp 29 pg 381
Bipolar Disorders: Monitoring for Medication Interactions for Lithium
1. NSAIDS and celecoxib increase the renal absorption of lithium.
2. Diuretics can cause decreased sodium levels which decreases lithium excretion which can leas to toxicity.
3. Medications with anticholinergic effects can cause urinary retention and polyuria leading to abdominal distention when used in conjunction with lithium.
Chp 9 pg 100
Cardiac Glycosides and Heart Failure: Findings to Report About Digoxin
1. The client taking digoxin should report any signs of hypokalemia such as nausea, vomiting or general weakness because of the risk for dysrhythmias.
2. The client should be measuring their pulse rate and should report any changes.
3. The client should monitor for GI effects such as anorexia, nausea, vomiting and abdominal pain and report that its presence to their provider.
4. Those on digoxin should monitor for CNS effects such as fatigue, weakness and vision change and report their presence to their provider.
Chp 21 pg 273
Miscellaneous Central Nervous System Medications: Teaching About Oxybutynin
1. The patient taking oxybutynin should report any CNS effects such as hallucinations, confusion or insomnia to their provider.
2. The nurse should educate the client taking oxybutynin about increasing dietary fiber and drinking 2-3 L/day to prevent constipation.
3. The patient can sip on fluids throughout the day to help reduce the effects of dry mouth from the adverse anticholinergic effects.
Chp 15 pg 190
Chronic Neurologic Disorders: Treating Complications of Myasthenia Gravis
1. Neostigmine, ambenonium, and pyridostigmine are medications used for the treatment of myasthenia gravis.
2. Edrophonium is the medication used to diagnosis myasthenia gravis.
3. Medications for complications should be taken at the same time everyday.
Chp 13 pg 148
Nonopioid Analgesics: Acetaminophen Toxicity
1. Early symptoms of acetaminophen toxicity are nausea, vomiting, diarrhea, sweating and abdominal discomfort.
2. To help prevent toxicity patients need to take the medication as prescribed and not exceed 4g/day.
3. The antidote for acetaminophen toxicity is acetylcysteine.
Chp 35 pg 463
Nonopioid Analgesics: Identifying Aspirin Toxicity
1. Salicylism is the milder form of aspiring toxicity, in which manifestations are tinnitus, sweating, headache, dizziness and respiratory alkalosis.
2. Aspirin toxicity progresses into high fever, acidosis, dehydration and electrolyte imbalances.
3. Aspirin toxicity is a medical emergencies and can eventually lead to coma and respiratory depression.
Chp 35 pg 461
Medications Affecting Blood Pressure: Evaluating Client Response to Captopril
1. If the client taking captopril develops dysgeusia, altered taste, the medication should be discontinued.
2. Captopril can have a client negatively respond to it by developing neutropenia, the medication should be discontinued.
3. Captopril should cause the client's blood pressure to be reduced, this is a positive response to the medication.
Chp 20 pg 250
Antibiotics Affecting Protein Synthesis: Adverse Effects of Gentamicin
1. The patient should stop taking gentamicin if tinnitus, hearing loss or headache occur because the medication can be ototoxic.
2. The nurse should report hematuria or cloudy urine for a patient taking gentamicin because it can have an adverse effect of acute tubular necrosis.
3. Gentamicin can have an adverse effect of hypersensitivity leading to rash, pruritus, paresthesia of the hands and feet, and urticaria.
Chp 45 pg 607
Endocrine Disorders: Therapeutic Effect of Propylthiouracil
1. A sign that propylthiouracil is effective would be vital signs within the expected reference range.
2. A therapeutic effect of propylthiouracil would be decreased T4 levels.
3. Propylthiouracil is effective with decreased signs of hyperthyroidism such as anxiety, tachycardia, palpations, increased appetite, abdominal cramping, heat intolerance, fever, diaphoresis, weight loss, and menstrual irregularity.
Chp 40 pg 527
Growth Factors: Documenting Effectiveness of Oprelvekin Therapy
1. Effectiveness of oprelvekin is noted by a platelet count that is greater than 50,00/mm3.
2. The goal of the use of oprelvekin is to reduce thrombocytopenia.
3. A theraputic effect of oprelvekin is to no longer need a platelet transfusion.
Chp 26 pg 346
Medications Affecting Coagulation: Reviewing Client Data During Heparin Infusion
1. During a heparin infusion vital signs should be monitored for signs of hemorrhage being increased heart rate and decreased blood pressure.
2. The client's aPTT should be monitored during the infusion, it should be 1.5-2 times the baseline.
3. The client's platelet count should be monitored during heparin therapy, the medication should be stopped if the platelets ares less than 100,000/mm3.
Chp 25 pg 322
Bone Disorders: Evaluating Client Understanding of Risedronate
1. The client should understand the purpose of risedronate is to inhibit bone resorption.
2. The client needs to understand that they need to sit upright or ambulate for 30 minutes after taking the medication orally to reduce esophagitis and esophageal ulceration.
3. The patient should understand that they should drink at least 8 oz of water after taking a tablet of risedronate and at least 2 oz after the liquid formula.
Chp 34 pg 451
Airflow Disorders: Medication to Prevent Exercise-Induced Bronchospasm
1. Albuterol is a medication that is for the prevention of exercise-induced asthma episodes.
2. Leukotriene modifiers such as montelukast or zileuton are used to prevent exercise-induced bronchospasm.
3. Levalbuterol and ipratropium can also be used to prevent exercise-induced bronchospasm.
Chp 17 pg 210
Peptic Ulcer Disease: Client Teaching About Sucralfate
1. The client on sucralfate should increase their fiber intake and drink at least 1,500 mL/day to attempt to prevent constipation.
2. Sucralfate should be taken 2-hours apart from phenytoin, digoxin, warfarin and ciprofloxacin in order to minimize the interactions.
3. Sucralfate should be taken 1 hour before meals and and at bedtime for a total of 4 doses a day.
Chp 28 pg 366
Medications Affecting Blood Pressure: Safe Medication Administration of Metoprolol
1. The patient taking metoprolol should not discontinue its use without speaking with a provider.
2. Metoprolol should be used cautiously in clients who have asthma.
3. Metoprolol should be used cautiously when patients have myasthenia gravis, diabetes, or depression.
Chp 20 pg 263
Airflow Disorders: Client Teaching for Methylprednisolone
1. Methyprednisolone is a IV form of a glucocorticoid.
2. A short-term IV agent is used for status asthmaticus.
3. Disturbances of fluid and electrolyte can develop, the client should notify their provider regarding symptoms such as weight gain, edema or muscle weakness.
Chp 17 pg 214
Medications Affecting Blood Pressure: Evaluating Client Understanding of Diltiazem
1. The client should understand that diltiazem can be used to treat angina pectoris, hypertension or cardiac dysrhythmias.
2. Diltiazem is a calcium channel blocker that can cause orthostatic hypotension, so the patient should raise slowly when changing positions.
3. The patient should be aware that grapefruit juice will increase the change of toxicity when on diltiazem.
Chp 20 pg 256
Medications Affecting the Blood Pressure: Potential Adverse Effects of Lisinopril
1. A potential adverse effect of lisinopril is first-dose orthostatic hypotension.
2. Lisinopril can cause a dry cough as an adverse effect.
3. Lisinopril can have the adverse effect of hyperkalemia (potassium > 5.0 mEq/L).
Chp 20 pg 250
Miscellaneous Pain Medications: Management of Migraines
1. The nurse should instruct the client to avoid triggers that cause stress and fatigue, like the consumption of alcohol and consuming tyramine-containing foods.
2. A migraine can be eased by lying in a dark and quiet place.
3. A number of medication can be taken to manage migraines such as NSAIDS, ergot alkaloids, serotonin receptor agonists, beta-blockers, anticonvulsants and more.
Chp 38 pg 500
Miscellaneous Central Nervous System Medications: Mixing and Administering Dantrolene
1. Dantrolene should be used cautiously in patients with impaired renal or liver function.
2. Dantrolene should not be stopped abruptly because of the risk of withdrawal reaction.
3. The client should avoid CNS depressants while taking dantrolene to prevent further CNS depressant effects of the medication.
Chp 15 pg 189
what is hydroxyzine (atarax)? what is it used for?
what is a common side effect of calcium carbonate?
The nurse is meeting with a couple who is having difficulty conceiving. The male storms out of the office yelling, "This is her fault; she is broken!" The nurse understands that what may be taking place?
what is peak time of Glargine (Lantus)
Sets found in the same folder
ATI Proctored Pharmacology Remediation
Pharmacology ATI Proctored NEW
COMPREHENSIVE ATI: PART B: PHARMACOLOGY
Comprehensive Predictor ATI Remediation
Sets with similar terms
2: EAQ & Practice Q's
PHARM Quiz 7
Patho Exam 1: Practice Exam
Other sets by this creator
Leadership Non-Proctored ATI Remediation
Nutrition ATI Remediation
Practice Community ATI Remediation
Other Quizlet sets
Adult exam #4
Pharm exam 2
pharm focused 1